Screening children at risk of developing inherited endocrine neoplasia syndromes

Clinical Endocrinology

Volumn 52, Issue 2, 2000, Pages 127-136

  Johnston, L B ^a   Chew, S L ^a   Trainer, P J ^a   Reznek, R ^a   Grossman, A B ^a   Besser, G M ^a   Monson, J P ^a   Savage, M O ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CLINICAL ARTICLE; ENDOCRINE TUMOR; FEMALE; GENETIC SCREENING; HEMANGIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPARATHYROIDISM; HYPOPHYSIS ADENOMA; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ISLET CELL TUMOR; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC SCREENING; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A;

EID: 0033984130     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00956.x     Document Type: Review

References (65)

1. Agarwal, S.C., Guru, S.C., Heppner, C., Erdos, M.R., Collins, K.M., Park, S.Y., Saggar, S., Chandrasekharappa, S.C., Collins, F.S., Speigel, A.M. & Burns, A.L. (1999) Menin interacts with the API transcription factor JunD and represses JunD-activated transcription. Cell, 96, 143-152.
2. Asai, N., Iwashita, T., Matsuyama, M. & Takahashi, M. (1995) Mechanisms of activation of the ret proto-oncogene by mutliple endocrine neoplasia type 2 mutations. Molecular Cell Biology, 15, 1613-1619.
3. Atuk, N.O., McDonald, T., Wood, T., Carpenter, J.T., Walzak, M.P., Donaldson, M. & Gillenwater, J.Y. (1979) Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family. Medicine (Baltimore), 58, 209-218.
4. Bassett, J.H., Forbes, S.A., Pannett, A.A., Lloyd, S.E., Christie, P.T., Wooding, C., Harding, B., Besser, G.M., Edwards, C.R., Monson, J.P., Sampson, J., Wass, J.A., Wheeler, M.H. & Thakker, R.V. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. American Journal of Human Genetics, 62, 232-244.
5. Blind, E., Schmidt-Gayk, H., Sinn, H.P., O'Connor, D.T. & Raue, F. (1992) Chromogranin A as tumor marker in medullary thyroid carcinoma. Thyroid, 2, 5-10.
6. Carlson, K.M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C.E., Wells, S.A.J., Goodfellow, P.J. & Donis-Keller, H. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proceddings National Academy of Science USA, 91, 1579-1583.
7. Casanova, S., Rosenberg-Bourgin, M., Farkas, D., Calmettes, C., Feingold, N., Heshmati, H.M., Cohen, R., Conte-Devolx, B., Guillausseau, P.J., Houdent, C., Bigorne, J.C., Boiteau, V., Caron, J. & Modigliani, E. (1993) Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clinical Endocrinology, 38, 531-537.
8. Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemi, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Zhuang, Z., Lubensky, I.A., Liotta, L.A., Crabtree, J.S., Wang, Y., Roe, B.A., Weisemann, J., Boguski, M.S., Agarwal, S.K., Kester, M.B., Kim, Y.S., Heppner, C., Dong, Q., Spiegel, A.M., Burns, A.L. & Marx, S.J. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science, 276, 404-407.
9. Chanson, P., Cadiot, G. & Murat, A. (1997) Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples de type 1. Hormone Research, 47, 211-220.
10. Chew, S.L. (1994) Phaeochromocytoma and familial tumour syndromes. Clinical Endocrinology, 40, 715-716.
11. Chew, S.L., Dacie, J.E., Reznek, R.H., Newbould, E.C., Sheaves, R., Trainer, P.J., Lowe, D.G., Shand, W.S., Hungerford, J., Besser, G.M. & Grossman, A. (1995) Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay. Quarterly Journal of Medicine, 87, 49-54.
12. Chew, S.L. & Eng, C. (1995) Multiple endocrine neoplasia type 2 and related genetic conditions. Current Opinion in Endocrinology and Diabetes, 2, 121-126.
13. Choyke, P.L., Glenn, G.M., Walther, M.M., Patronas, N.J., Linehan, W.M. & Zbar, B. (1995) von Hippel-Lindau disease: genetic, clinical, and imaging features [published erratum appears in Radiology (1995) 196, 582] Radiology, 194, 629-642.
14. Choyke, P.L., Glenn, G.M., Walther, M.M., Zbar, B., Weiss, G.H., Alexander, R.B., Hayes, W.S., Long, J.P., Thakore, K.N. & Linehan, W.M. (1992) The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. American Journal of Roentgenology, 159, 1229-1234.
15. Duan, D.R., Pause, A., Burgess, W.H., Aso, T., Chen, D.Y., Garrett, K.P., Conaway, R.C., Conaway, J.W., Linehan, W.M. & Klausner, R.D. (1995) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science, 269, 1402-1406.
16. Eisenhofer, G., Lendres, J.W., Linehan, W.M., Walther, M.M., Goldstein, D.S. & Keiser, H.R. (1999) Plasma normetanephrine and metanephrine for detecting phaeochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine, 340, 1872-1879.
17. Eng, C., Smith, D.P., Mulligan, L.M., Nagai, M.A., Healey, C.S., Ponder, M.A., Gardner, E., Scheumann, G.F., Jackson, C.E., Tunnacliffe, A. & E.T.A.L. (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Human Molecular Genetics, 3, 237-241.
18. Gagel, R.F., Cote, G.J., Martins Bugalho, M.J., Boyd, A.E., 3rd, C.u.m.m.i.n.g.s., T., Goepfert, H., Evans, D.B., Cangir, A., Khorana, S. & Schultz, P.N. (1995) Clinical use of molecular information in the management of multiple endocrine neoplasia type 2 A. Journal of Internal Medicine, 238, 333-341.
19. Gagel, R.F., Robinson, M.F., Donovan, D.T. & Alford, B.R. (1993) Clinical review 44: Medullary thyroid carcinoma: recent progress. Journal of Clinical Endocrinology Metabolism, 76, 809-814.
20. Gagel, R.F., Tashjian, A.H.J.R., Cummings, T., Papathanasopoulos, N., Kaplan, M.M., Delellis, R.A., Wolfe, H.J. & Reichlin, S. (1988) The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. New England Journal of Medicine, 318, 478-484.
21. Gill, J.R., Reyes-Mugica, M., Iyengar, S., Kidd, K.K., Touloukian, R.J., Smith, C., Keller, M.S. & Genel, M. (1996) Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy. Journal of Pediatrics, 129, 459-464.
22. Heshmati, H.M., Gharib, H., Khosla, S., Abu-Lebdeh, H.S., Lindor, N.M., Thibodeau & S.N. (1997) Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance. Mayo Clinical Proceedings, 72, 430-436.
23. Hoff, A.O. & Gagel, R.F. (1997) Multiple endocrine neoplasia types 1 and 2: phenotype, genotype, diagnosis and therapeutic plan with special reference to children and adolescents. Current Opinion in Endocrinology and Diabetes, 4, 91-99.
24. Hofstra, R.M., Landsvater, R.M., Ceccherini, I., Stulp, R.P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J.W., Van Amstel, H.K., Romeo, G., Lips, C.J. & Buys, C.H. (1994) A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature, 367, 375-376.
25. Horton, W.A., Wong, V. & Eldridge, R. (1976) Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Archives Internal Medicine, 136, 769-777.
26. Hough, D.M., Stephens, D.H., Johnson, C.D. & Binkovitz, L.A. (1994) Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. American Journal of Roentgenology, 162, 1091-1094.
27. Howe, J.R., Norton, J.A. & Wells, S.A. (1993) Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery, 114, 1070-1077.
28. Hsiao, R.J., Neumann, H.P., Farmer, R.J., Barbosa, J.A. & O'Connor, D.T. (1990) Chromogranin A in familial phaeochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution. American Journal of Medicine, 88, 607-613.
29. Huang, S.C., Zhuang, Z., Weil, R.J., Pack, S., Wang, C., Krattzch, H.C., Pham, T.A. & Lubensky, I.A. (1999) Nuclear/cytoplasmic localisation of theutliple endocrine neoplasia type 1 gene product, menin. Laboratory Investigation, 79, 301-310.
30. Iliopoulos, O., Levy, A.P., Jiang, C., Kaelin, W.G. & Goldberg, M.A. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proceedings National Academy of Science USA, 93, 10595-10599.
31. Iliopoulos, O., Ohh, M. & Kaelin, W.G. (1998) pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proceedings National Academy of Science USA, 95, 11661-11666.
32. Kahn, M.A., Cote, G.J. & Gagel, R.F. (1996) RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 82, 288-294.
33. Kennedy, J.W. & Dluhy, R.G. (1997) The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management. Yale Journal of Biological Medicine, 70 (5-6), 565-575.
34. Kibel, A., Iliopoulos, O., Decaprio, J.A. & Kaelin, W.G. J.R. (1995) Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science, 269, 1444-1446.
35. Kraimps, J.L., Denizot, A., Camaille, B., Henry, J.F., Proye, C., Bacourt, F., Sarfati, E., Dupond, J.L., Maes, B., Travagli, J.P., Boneu, A., Roger, P., Houdent, C., Barbier, J. & Modigliani, E. (1996) Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons. World Journal of Surgery, 20, 808-812.
36. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.M., Orcutt, M.L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L. & E.T.A.L. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260, 1317-1320.
37. Learoyd, D.L., Capes, G.C. & Robinson, B.G. (1997) Multiple endocrine neoplasia type 2 and glial cell line-derived neurotrophic factor. Current Opinion in Endocrinology and Diabetes, 4, 130-137.
38. Maddock, I.R., Moran, A., Maher, E.R., Teare, M.D., Norman, A., Payne, S.J., Whitehouse, R., Dodd, C., Lavin, M., Hartley, N., Super, M. & Evans, D.G. (1996) A genetic register for von Hippel-Lindau disease. Journal of Medical Genetics, 33, 120-127.
39. Maher, E.R., Webster, A.R., Richards, F.M., Green, J.S., Crossey, P.A., Payne, S.J. & Moore, A.T. (1996) Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. Journal of Medical Genetics, 33, 328-332.
40. Maher, E.R., Yates, J.R., Harries, R., Benjamin, C., Harris, R., Moore, A.T. & Ferguson-Smith, M.A. (1990) Clinical features and natural history of von Hippel-Lindau disease. Quarterly Journal of Medicine, 77, 1151-1163.
41. Mallette, L.E. (1994) Management of hyperparathyroidism in multiple endocrine neoplasia syndromes and other familial endocrinopathies. Endocrinology and Metabolism Clinics of North America, 23, 19-36.
42. Marsh, D.J., McDowall, D., Hyland, V.J., Andrew, S.D., Schnitzler, M., Gaskin, E.L., Nevell, D.F., Diamond, T., Delbridge, L., Clifton-Bligh, P. & Robinson, B.G. (1996) The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families. Clinical Endocrinology, 44, 213-220.
43. Melmon, K.L. & Rosen, S.W. (1964) Lindau's disease. Review of the literature and study of a large kindred. American Journal of Medicine, 36, 595-617.
44. Mergo, P.J., Helmberger, T.K., Buetow, P.C., Helmberger, R.C. & Ros, P.R. (1997) Pancreatic neoplasms: MR imaging and pathologic correlation. Radiographics , 17, 281-301.
45. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B., Gardner, E., Ponder, M.A., Frilling, A., Jackson, C.E., Lehnen, H. & E.T.A.L. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics, 6, 70-74.
46. Mutch, M.G., Frisella, M.M., Debenedetti, M.K., Doherty, G.M., Norton, J.A., Wells, S.A.J. & Lairmore, T.C. (1997) Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1. Surgery, 122, 1012-1019.
47. Neumann, H.P., Eggert, H.R., Scheremet, R., Schumacher, M., Mohadjer, M., Wakhloo, A.K., Volk, B., Hettmannsperger, U., Riegler, P., Schollmeyer, P. & E.T.A.L. (1992) Central nervous system lesions in von Hippel-Lindau syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 55, 898-901.
48. Neumann, H.P., Eggert, H.R., Weigel, K., Friedburg, H., Wiestler, O.D. & Schollmeyer, P. (1989) Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. Journal of Neurosurgery, 70, 24-30.
49. Newbould, E.C., Ross, G.A., Dacie, J.E., Bouloux, P.M., Besser, G.M. & Grossman, A. (1991) The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas. Clinical Endocrinology, 35, 55-59.
50. Ohh, M., Yauch, R.L., Lonergan, K.M., Whaley, J.M., Stemmer-Rachamimov, A.O., Louis, D.N., Gavin, B.J., Kley, N., Kaelin, W.G., J.R. & Iliopoulos, O. (1998) The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Molecular Cell, 1, 959-968.
51. Pacini, F., Romei, C., Miccoli, P., Elisei, R., Molinaro, E., Mancusi, F., Iacconi, P., Basolo, F., Martino, E. & Pinchera, A. (1995) Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. Surgery, 118, 1031-1035.
52. Raue, F. (1996) Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Clinical Endocrine Oncology, (eds, P.J. Jenkins, R. Sheaves & J.A. Wass), pp. 445-452. Blackwell Science, Oxford
53. Raue, F., Kotzerke, J., Reinwein, D. & E.T.A.L. (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clinical Investigation, 71, 7-12.
54. Ross, G.A., Newbould, B.C., Thomas, J., Bouloux, P.M., Besser, G.M., Perrett, D. & Grossman, A. (1993) Plasma and 24 h-urinary catecholamine concentrations in normal and patient populations. Annals Clinical Biochemistry, 30, 38-44.
55. Rossel, M., Schuffenecker, I., Schlumberger, M., Bonnardel, C., Modigliani, E., Gardet, P., Navarro, J., Luo, Y., Romeo, G., Lenoir, G. & E.T.A.L. (1995) Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families. Human Genetics, 95, 403-406.
56. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D.P., Dathan, N.A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M.H. & E.T.A.L. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science, 267, 381-383.
57. Skinner, M.A., Debenedetti, M.K., Moley, J.F., Norton, J.A., Wells, S.A. & J.R. (1996) Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Journal of Pediatric Surgery, 31, 177-181.
58. Skogseid, B., Grama, D., Rastad, J., Eriksson, B., Lindgren, P.G., Ahlstrom, H., Lorelius, L.E., Wilander, E., Akerstrom, G. & Oberg, K. (1995) Operative tumour yield obviates preoperative pancreatic tumour localisation in multiple endocrine neoplasia type I. Journal of Internal Medicine, 238, 281-288.
59. Skogseid, B., Rastad, J. & Oberg, K. (1994) Multiple endocrine neoplasia type I: clinical features and screening. Endocrinology and Metabolism Clinics of North America, 23, 1-18.
60. Tagge, E.P., Hill, J.G., Tagge, D.U. & MacPherson, R. (1995) Pancreatic surgery in children. Current Opinion in Pediatrics, 7, 342-348.
61. Teh, B.T. (1998) Recent advances in multiple endocrine neoplasia type 1. Current Opinion in Endocrinology and Diabetes, 5, 35-39.
62. Trainer, P.J. & Besser, G.M. (1995) The Barts Endocrine Protocols. Churchill Livingstone, London.
63. Trump, D., Farren, B., Wooding, C., Pang, J.T., Besser, G.M., Buchanan, K.D., Edwards, C.R., Heath, D.A., Jackson, C.E., Jansen, S., Lips, K., Monson, J.P., O'Halloran, D., Sampson, J., Shalet, S.M., Wheeler, M.H., Zink, A. & Thakker, R.V. (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Quarterly Journal of Medicine, 89, 653-669.
64. Tsai, M.S., Ledger, G.A., Khosla, S., Gharib, H. & Thibodeau, S.N. (1994) Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET protooncogene. Journal of Clinical Endocrinology and Metabolism, 78, 1261-1264.
65. Zedenius, J., Larsson, C., Bergholm, U., Bovee, J., Svensson, A., Hallengren, B., Grimelius, L., Backdahl, M., Weber, G. & Wallin, G. (1995) Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 80, 3088-3090.